Low-Density Lipoprotein Cholesterol Size
LDL C S
Description
"Low-Density Lipoprotein (LDL) Cholesterol Size" test determines whether your LDL particles are small and dense or large and buoyant. Smaller particles are more likely to contribute to plaque buildup, increasing heart disease risk. Doctors use this test when deeper insight is needed beyond standard LDL values. A blood sample reveals particle size distribution, helping tailor interventions. Based on results, care plans may include dietary changes, exercise, or medications. Tracking LDL size helps refine risk and improve long-term heart health.
Test Category
Lipids, Proteins
Procedure
Invasive
Sample Type
Blood – Serum
Units
Nanometers
Procedure Category
Blood Draw
Test Group
Lipoprotein Fractionation Group, Male Health Group, Female Health Group, Complete Cardiovascular Group
Test Group Description
Complete Cardiovascular Group: This group contains comprehensive tests for an extensive evaluation of cardiovascular health, providing thorough insights into heart-related conditions beyond basic assessments. Female Health Group: A comprehensive array of tests provides insights into various aspects of female health and wellness, aiding in the evaluation and management of overall health for females. Male Health Group: A comprehensive array of tests provides insights into various aspects of male health and wellness, aiding in the evaluation and management of overall health for men. Lipoprotein Fractionation Group: Analyzes lipoprotein fractions through NMR technology, providing detailed insights into lipid metabolism and cardiovascular health.
Optimal Range
For All Individuals:
Conventional Unit: >21.00 nm
SI Unit: Not Applicable
Normal Range
For All Individuals:
Conventional Unit: 20.00–22.30 nm
SI Unit: Not Applicable
Results That Differ From The Norm (Direct and Indirect Causes)
Increased levels may indicate:
Chronic kidney disease
Familial hypercholesterolemia (Genetic disorder causing high levels of cholesterol)
Hypothyroidism (Underactive thyroid gland)
Insulin resistance (Reduced responsiveness to insulin)
Medications (such as antipsychotics and corticosteroids)
Metabolic syndrome (cluster ...
Key Reasons For Testing
Assessment of Cardiovascular Risk: Smaller, denser LDL particles increase atherosclerosis risk.
Predictive Value for Atherosclerosis: Correlates with higher cardiovascular event susceptibility.
Personalized Treatment Approaches: Guides tailored therapies based on individual risk profiles.
Response to Lifestyle Modifications: Reflects the impact of diet and exercise on cardiovascular health.
Early Detection of Atherosclerosis: Identifies elevated arterial plaque risk associated with small LDL particles.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Superko HR, Gadesam RR. Is it LDL particle size or number that correlates with risk for cardiovascular disease? Curr Atheroscler Rep. 2008;10(5):377-385.
[2] Rosenson RS, Otvos JD, Freedman DS. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol. 2002;90(2):89-94.
[3] Blake GJ, Otvos JD, Rifai N, Ridker PM. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation. 2002;106(15):1930-1937.
[4] Mora S, Szklo M, Otvos JD, et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2007;192(1):211-217.
[5] St-Pierre AC, Cantin B, Dagenais GR, et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol. 2005;25(3):553-559.
[6] Otvos JD, Jeyarajah EJ, Cromwell WC. Measurement issues related to lipoprotein heterogeneity. Am J Cardiol. 2002;90(8A):22i-29i.
[7] Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Schaefer EJ. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12(2):187-195.
[8] Lamarche B, St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Després JP. A prospective, population-based study of low-density lipoprotein particle size as a risk factor for ischemic heart disease in men. Can J Cardiol. 2001;17(8):859-865.
[9] Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PW. Relation of lipoprotein subclasses as measured by nuclear magnetic resonance spectroscopy to coronary artery calcification in the Framingham Heart Study. Clin Chem. 2004;50(7):1187-1197.
[10] Garvey WT, Kwon S, Zheng D, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 2003;52(2):453-462.
[11] Musunuru K. Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids. 2010;45(10):907-914.
[12] Kuller L, Arnold A, Tracy R, et al. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 2002;22(7):1175-1180.
[13] McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PW, Schaefer EJ. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arterioscler Thromb. 1990;10(4):458-466.
[14] Koba S, Hirano T, Tsunoda F, et al. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease. Am Heart J. 2002;144(6):1026-1035.